Pharma

Cipla on Tuesday reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729 crore for the third quarter ended on December 31, 2021

Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).

The pharma industry is expecting an increase in the overall fund allocation for the healthcare sector, focus on policies that encourage R&D activities

The Indian equity benchmarks on Thursday extended fall to the third straight session due to selling pressure in information technology, consumer products and pharma stocks. The 30-share BSE Sensex slumped 634 points or 1.06 per cent to close at 59,465, while the broader NSE Nifty settled 181 points or 1.01 per cent lower at 17,757. In late deals, t...

The Indian equity benchmarks on Tuesday plunged into red after opening higher, led by losses in auto, information technology and pharma stocks.

The Indian equity benchmarks on Tuesday started trading in green amid positive global cues.

India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.

ICRA has said that the pharmaceutical industry is estimated to grow at the rate of 9 per cent to 11 per cent in 2021-22 due to emerging markets

Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.

Sensex, Nifty Updates: At 12:57 pm, the NSE Nifty 50 index was up 0.21 per cent at 17,248, and the benchmark S&P BSE Sensex rose 0.21 per cent to 57,9292.45.

A lawyer for claimants suing Johnson & Johnson over its baby powder wants a bankruptcy judge to force the pharma giant to produce requested information, saying it's hindering efforts to investigate the case.

Sensex, Nifty Updates: The Nifty pharma index was the top gainer, rising 0.9 per cent a day after India approved Merck's COVID-19 pill and two more vaccines for emergency use.

Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday

With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio

Ajanta Pharma Share Price: On Tuesday, shares of Ajanta Pharma settled 3.83 per cent higher at Rs 2,263.90 apiece on the BSE.

Cipla on Tuesday reported a 2.6 per cent decline in its consolidated profit after tax to Rs 729 crore for the third quarter ended on December 31, 2021

Dr Ateeq is a recipient of the Shanti Swarup Bhatnagar Prize in Medical Sciences (2020). She is also an Elected Fellow of the National Academy of Sciences, India (NASI) and the Indian Academy of Sciences, Bangalore (IASc).

The pharma industry is expecting an increase in the overall fund allocation for the healthcare sector, focus on policies that encourage R&D activities

The Indian equity benchmarks on Thursday extended fall to the third straight session due to selling pressure in information technology, consumer products and pharma stocks. The 30-share BSE Sensex slumped 634 points or 1.06 per cent to close at 59,465, while the broader NSE Nifty settled 181 points or 1.01 per cent lower at 17,757. In late deals, t...

The Indian equity benchmarks on Tuesday plunged into red after opening higher, led by losses in auto, information technology and pharma stocks.

The Indian equity benchmarks on Tuesday started trading in green amid positive global cues.

India's Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters.

ICRA has said that the pharmaceutical industry is estimated to grow at the rate of 9 per cent to 11 per cent in 2021-22 due to emerging markets

Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.

Sensex, Nifty Updates: At 12:57 pm, the NSE Nifty 50 index was up 0.21 per cent at 17,248, and the benchmark S&P BSE Sensex rose 0.21 per cent to 57,9292.45.

A lawyer for claimants suing Johnson & Johnson over its baby powder wants a bankruptcy judge to force the pharma giant to produce requested information, saying it's hindering efforts to investigate the case.

Sensex, Nifty Updates: The Nifty pharma index was the top gainer, rising 0.9 per cent a day after India approved Merck's COVID-19 pill and two more vaccines for emergency use.

Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday

With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versio

Ajanta Pharma Share Price: On Tuesday, shares of Ajanta Pharma settled 3.83 per cent higher at Rs 2,263.90 apiece on the BSE.